Cargando…
Aryl Hydrocarbon Receptor Agonist VAF347 Impedes Retinal Pathogenesis in Diabetic Mice
Diabetic retinopathy is the leading cause of blindness in the working-age population worldwide. Although the cause of diabetic retinopathy is multifactorial, IL-17A is a prevalent inflammatory cytokine involved in the promotion of diabetes-mediated retinal inflammation and the progression of diabeti...
Autores principales: | Zapadka, Thomas E., Lindstrom, Sarah I., Batoki, Julia C., Lee, Chieh A., Taylor, Brooklyn E., Howell, Scott J., Taylor, Patricia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122442/ https://www.ncbi.nlm.nih.gov/pubmed/33919327 http://dx.doi.org/10.3390/ijms22094335 |
Ejemplares similares
-
Retinal Inflammation, Oxidative Stress, and Vascular Impairment Is Ablated in Diabetic Mice Receiving XMD8-92 Treatment
por: Howell, Scott J., et al.
Publicado: (2021) -
The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells
por: Ibabao, Christopher N., et al.
Publicado: (2015) -
RORγt Inhibitor-SR1001 Halts Retinal Inflammation, Capillary Degeneration, and the Progression of Diabetic Retinopathy
por: Zapadka, Thomas E., et al.
Publicado: (2020) -
IL-17A Enhances Retinal Neovascularization
por: Taylor, Brooklyn E., et al.
Publicado: (2023) -
Inhibition of CD40-TRAF6-dependent inflammatory activity halts the onset of diabetic retinopathy in streptozotocin-diabetic mice
por: Howell, Scott J., et al.
Publicado: (2022)